Delivery Order SPE2DB22D2211-SPE2DB24FRGWL

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,173,842 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The delivery order has a ceiling value of $1,160.03 and is a firm fixed-price contract. This award is not a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,912,417 units of Atovaquone-Proguanil 250-100mg tablets. The contract has a firm-fixed price of $4,079.80 and a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,470.75 firm fixed price delivery order is for Atovaquone-Proguanil 250-100 100s, a malaria medication. The contract has a completion date of May 16, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 IDC with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,138.75 firm fixed price contract is for the supply of 4,564,530,971 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows DLA to...
This is a $1,871.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a malaria treatment medication. The delivery order has a completion date of July 11, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also holds a $999,999,999.00...
This is a $225,650.88 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Atovaquone-Proguanil 250-100 100s, a malaria medication, with an ultimate completion date of April 28, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,009.57, is for the procurement of Atovaquone-Proguanil 250-100 UD 24S, a prescription medication used for the treatment and prevention of malaria. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA,...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is for the delivery of 4,565,910 units of Atovaquone-Proguanil 250-100 mg tablets over a two-year period ending on September 24, 2024. The $9,495.07 firm-fixed-price delivery order is not set aside for any specific business category. Amerisourcebergen, the prime contractor, has been awarded this order as part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,916.92 fixed-price contract is for the supply of 100 units of the drug Atovaquone-Proguanil, which is used for the prevention and treatment of malaria. This award is a delivery order under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $2,126.67 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the supply of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FRGWL
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,712 units of the anti-malarial drug combination Atovaquone-Proguanil 250-100 mg. The delivery order, valued at $6,806.00, was issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that has a ceiling value of up to $999,999,999 and runs through December 2025. This contract does not have a set-aside designation and is for firm fixed-price delivery of the pharmaceutical product by September 9, 2024. Amerisourcebergen, as a large for-profit organization, is the prime contractor for this award, which supports the medical supply needs of military treatment facilities and other federal healthcare providers.

Generated 12/6/24, 9:21 AM